Inhibitors of the sodium-glucose cotransporter 2 (SGLT2i) and glucagon-like peptide-1 receptor agonists (GLP-1 RA) have been studied and trialled in type 2 diabetes with an overwhelming body of evidence supporting their use in type 2 diabetes [10]
Health insurance may not cover the cost of weight loss medications, but you have the right to appeal the decision if your insurer denies coverage
Think of it like two students studying for the same exam
Nausea, constipation, or fatigue are common early side effects but typically improve as your body adapts
Youll work with Bonnie Lea Davis, FNP-C, review your options, and receive guidance on whether Semaglutide, Tirzepatide, oral drops, microdosing, or another plan may be medically appropriate
Is Fibromyalgia an Autoimmune Disease